TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects

J Neuroimmunol. 2009 Nov 30;216(1-2):92-7. doi: 10.1016/j.jneuroim.2009.08.013. Epub 2009 Sep 19.

Abstract

The associations of inflammation/immune responses with clinical presentations of Alzheimer's disease (AD) remain unclear. We hypothesized that TNF-alpha and elevated antibodies to periodontal bacteria would be greater in AD compared to normal controls (NL) and their combination would aid clinical diagnosis of AD. Plasma TNF-alpha and antibodies against periodontal bacteria were elevated in AD patients compared with NL and independently associated with AD. The number of positive IgG to periodontal bacteria incremented the TNF-alpha classification of clinical AD and NL. This study shows that TNF-alpha and elevated numbers of antibodies against periodontal bacteria associate with AD and contribute to the AD diagnosis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Alzheimer Disease / immunology*
  • Alzheimer Disease / microbiology*
  • Alzheimer Disease / physiopathology
  • Antibodies / analysis
  • Antibodies / metabolism*
  • Bacteria / immunology
  • Biomarkers / analysis
  • Biomarkers / metabolism
  • Causality
  • Comorbidity
  • Diagnosis, Differential
  • Female
  • Humans
  • Male
  • Middle Aged
  • Periodontitis / immunology*
  • Periodontitis / microbiology*
  • Periodontitis / physiopathology
  • Periodontium / immunology
  • Periodontium / microbiology
  • Predictive Value of Tests
  • Tumor Necrosis Factor-alpha / analysis
  • Tumor Necrosis Factor-alpha / metabolism*
  • Up-Regulation / immunology

Substances

  • Antibodies
  • Biomarkers
  • Tumor Necrosis Factor-alpha